SWOG clinical trial number
SWOG-8741
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Carcinoma of the Breast
Closed
Phase
Accrual
63%
Published
Abbreviated Title
A Phase II Study of Recombinant Tumor Necrosis Factor (rTNF) in Patients with Refractory Carcinoma of the Breast
Activated
09/15/1988
Closed
11/15/1990
Publication Information Expand/Collapse
1991
A Southwest Oncology Group phase II trial of recombinant tumor necrosis factor in metastatic breast cancer.